Lead Optimization of Butyrolactone-I as Orally Bioavailable Anti-Allergic Agent Targeting FcγRIIBn

Authors: Chun-Lan Xie, Hong-Xiu Xiao, Pei-Fang Song, Qing-Mei Liu, Haoxiang Wei, Liang Wu, Guang-Hao Zhu, Guang-Ming Liu*, Yandong Zhang*, Ping Wang*, and Xian-Wen Yang*

Link: https://pubs.acs.org/doi/10.1021/acs.jmedchem.4c00354